ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

Summit Conference Reviews Leads In Leukemia, Lymphoma

January 8, 1982

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

In Brief: Illinois Legislature Votes Nearly $1 Million To ICC; Carolyne Davis Resigns From HCFA Jobs

August 2, 1985

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991